2024 ICD-10-CM Diagnosis Code T44.5X1D

Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), subsequent encounter

ICD-10-CM Code:
T44.5X1D
ICD-10 Code for:
Poisoning by predom beta-adrenocpt agonists, acc, subs
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Not chronic
Code Navigator:

Code Classification

  • Injury, poisoning and certain other consequences of external causes
    (S00–T88)
    • Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
      (T36-T50)
      • Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system
        (T44)

T44.5X1D is a billable diagnosis code used to specify a medical diagnosis of poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), subsequent encounter. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.

T44.5X1D is a subsequent encounter code, includes a 7th character and should be used after the patient has completed active treatment for a condition like poisoning by predominantly beta-adrenoreceptor agonists accidental (unintentional). According to ICD-10-CM Guidelines a "subsequent encounter" occurs when the patient is receiving routine care for the condition during the healing or recovery phase of treatment. Subsequent diagnosis codes are appropriate during the recovery phase, no matter how many times the patient has seen the provider for this condition. If the provider needs to adjust the patient's care plan due to a setback or other complication, the encounter becomes active again.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Accidental poisoning by adrenalin
  • Accidental poisoning by adrenergics
  • Beta-adrenoceptor agonist overdose
  • Beta-adrenoceptor agonist poisoning
  • Poisoning by epinephrine

Clinical Classification

Clinical Information

  • Beclomethasone

    an anti-inflammatory, synthetic glucocorticoid. it is used topically as an anti-inflammatory agent and in aerosol form for the treatment of asthma.
  • Budesonide

    a glucocorticoid used in the management of asthma, the treatment of various skin disorders, and allergic rhinitis.
  • Budesonide, Formoterol Fumarate Drug Combination

    a pharmaceutical preparation of budesonide and formoterol fumarate that is used as an anti-asthmatic agent and for the treatment of chronic obstructive pulmonary disease.
  • Dobutamine

    a catecholamine derivative with specificity for beta-1 adrenergic receptors. it is commonly used as a cardiotonic agent after cardiac surgery and during dobutamine stress echocardiography.
  • Echocardiography, Stress

    a method of recording heart motion and internal structures by combining ultrasonic imaging with exercise testing (exercise test) or pharmacologic stress.
  • Epinephrine

    the active sympathomimetic hormone from the adrenal medulla. it stimulates both the alpha- and beta- adrenergic systems, causes systemic vasoconstriction and gastrointestinal relaxation, stimulates the heart, and dilates bronchi and cerebral vessels. it is used in asthma and cardiac failure and to delay absorption of local anesthetics.
  • Racepinephrine

    a racemic mixture of d-epinephrine and l-epinephrine.
  • Receptors, Adrenergic

    cell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. the two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. adrenergic receptors may also be classified according to the subtypes of g-proteins with which they bind; this scheme does not respect the alpha-beta distinction.
  • Isoetharine

    adrenergic beta-2 agonist used as bronchodilator for emphysema, bronchitis and asthma.
  • Prenalterol

    a partial adrenergic agonist with functional beta 1-receptor specificity and inotropic effect. it is effective in the treatment of acute cardiac failure, postmyocardial infarction low-output syndrome, shock, and reducing orthostatic hypotension in the shy-rager syndrome.
  • Procaterol

    a long-acting beta-2-adrenergic receptor agonist.
  • Ritodrine

    an adrenergic beta-2 agonist used to control premature labor.
  • Xamoterol

    a phenoxypropanolamine derivative that is a selective beta-1-adrenergic agonist.

Coding Guidelines

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined. If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system (T44). Use the following options for the aplicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Present on Admission (POA)

T44.5X1D is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.

CMS POA Indicator Options and Definitions

POA IndicatorReason for CodeCMS will pay the CC/MCC DRG?
YDiagnosis was present at time of inpatient admission.YES
NDiagnosis was not present at time of inpatient admission.NO
UDocumentation insufficient to determine if the condition was present at the time of inpatient admission.NO
WClinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission.YES
1Unreported/Not used - Exempt from POA reporting. NO

Convert T44.5X1D to ICD-9-CM

  • ICD-9-CM Code: V58.89 - Other specfied aftercare
    Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Table of Drugs and Chemicals

The parent code T44.5X1 of the current diagnosis code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.

According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.

Substance Poisoning
Accidental
(unintentional)
Poisoning
Accidental
(self-harm)
Poisoning
Assault
Poisoning
Undetermined
Adverse
effect
Underdosing
AdrenalineT44.5X1T44.5X2T44.5X3T44.5X4T44.5X5T44.5X6
AngiotensinT44.5X1T44.5X2T44.5X3T44.5X4T44.5X5T44.5X6
BeclomethasoneT44.5X1T44.5X2T44.5X3T44.5X4T44.5X5T44.5X6
BudesonideT44.5X1T44.5X2T44.5X3T44.5X4T44.5X5T44.5X6
DobutamineT44.5X1T44.5X2T44.5X3T44.5X4T44.5X5T44.5X6
EpinephrineT44.5X1T44.5X2T44.5X3T44.5X4T44.5X5T44.5X6
IsoetharineT44.5X1T44.5X2T44.5X3T44.5X4T44.5X5T44.5X6
PrenalterolT44.5X1T44.5X2T44.5X3T44.5X4T44.5X5T44.5X6
ProcaterolT44.5X1T44.5X2T44.5X3T44.5X4T44.5X5T44.5X6
RacepinefrinT44.5X1T44.5X2T44.5X3T44.5X4T44.5X5T44.5X6
RitodrineT44.5X1T44.5X2T44.5X3T44.5X4T44.5X5T44.5X6
XamoterolT44.5X1T44.5X2T44.5X3T44.5X4T44.5X5T44.5X6

Patient Education


Medication Errors

Medicines treat infectious diseases, prevent problems from chronic diseases, and ease pain. But medicines can also cause harmful reactions if not used correctly. Errors can happen in the hospital, at the health care provider's office, at the pharmacy, or at home. You can help prevent errors by:

  • Knowing your medicines. When you get a prescription, ask the name of the medicine and check to make sure that the pharmacy gave you the right medicine. Make sure that you understand how often you should take the medicine and how long you should take it.
  • Keeping a list of medicines.
    • Write down all of the medicines that you are taking, including the names of your medicines, how much you take, and when you take them. Make sure to include any over-the-counter medicines, vitamins, supplements, and herbs that you take.
    • List the medicines that you are allergic to or that have caused you problems in the past.
    • Take this list with you every time you see a health care provider.
  • Reading medicine labels and following the directions. Don't just rely on your memory - read the medication label every time. Be especially careful when giving medicines to children.
  • Asking questions. If you don't know the answers to these questions, ask your health care provider or pharmacist:
    • Why am I taking this medicine?
    • What are the common side effects?
    • What should I do if I have side effects?
    • When should I stop this medicine?
    • Can I take this medicine with the other medicines and supplements on my list?
    • Do I need to avoid certain foods or alcohol while taking this medicine?

Food and Drug Administration


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.